301 related articles for article (PubMed ID: 29330423)
1. T cell immunity to Zika virus targets immunodominant epitopes that show cross-reactivity with other Flaviviruses.
Reynolds CJ; Suleyman OM; Ortega-Prieto AM; Skelton JK; Bonnesoeur P; Blohm A; Carregaro V; Silva JS; James EA; Maillère B; Dorner M; Boyton RJ; Altmann DM
Sci Rep; 2018 Jan; 8(1):672. PubMed ID: 29330423
[TBL] [Abstract][Full Text] [Related]
2. T Cell Responses Induced by Attenuated Flavivirus Vaccination Are Specific and Show Limited Cross-Reactivity with Other Flavivirus Species.
Grifoni A; Voic H; Dhanda SK; Kidd CK; Brien JD; Buus S; Stryhn A; Durbin AP; Whitehead S; Diehl SA; De Silva AD; Balmaseda A; Harris E; Weiskopf D; Sette A
J Virol; 2020 May; 94(10):. PubMed ID: 32132233
[TBL] [Abstract][Full Text] [Related]
3. Cross-Reactive T Cell Immunity to Dengue and Zika Viruses: New Insights Into Vaccine Development.
Elong Ngono A; Shresta S
Front Immunol; 2019; 10():1316. PubMed ID: 31244855
[TBL] [Abstract][Full Text] [Related]
4. Strong CD4 T Cell Responses to Zika Virus Antigens in a Cohort of Dengue Virus Immune Mothers of Congenital Zika Virus Syndrome Infants.
Reynolds CJ; Watber P; Santos CNO; Ribeiro DR; Alves JC; Fonseca ABL; Bispo AJB; Porto RLS; Bokea K; de Jesus AMR; de Almeida RP; Boyton RJ; Altmann DM
Front Immunol; 2020; 11():185. PubMed ID: 32132999
[No Abstract] [Full Text] [Related]
5. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q
Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880
[TBL] [Abstract][Full Text] [Related]
6. STAT5: a Target of Antagonism by Neurotropic Flaviviruses.
Zimmerman MG; Bowen JR; McDonald CE; Young E; Baric RS; Pulendran B; Suthar MS
J Virol; 2019 Dec; 93(23):. PubMed ID: 31534033
[TBL] [Abstract][Full Text] [Related]
7. Cross-Reactivity and Anti-viral Function of Dengue Capsid and NS3-Specific Memory T Cells Toward Zika Virus.
Lim MQ; Kumaran EAP; Tan HC; Lye DC; Leo YS; Ooi EE; MacAry PA; Bertoletti A; Rivino L
Front Immunol; 2018; 9():2225. PubMed ID: 30327651
[TBL] [Abstract][Full Text] [Related]
8. Sustained Specific and Cross-Reactive T Cell Responses to Zika and Dengue Virus NS3 in West Africa.
Herrera BB; Tsai WY; Chang CA; Hamel DJ; Wang WK; Lu Y; Mboup S; Kanki PJ
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321308
[TBL] [Abstract][Full Text] [Related]
9. DNA-immunisation with dengue virus E protein domains I/II, but not domain III, enhances Zika, West Nile and Yellow Fever virus infection.
Slon Campos JL; Poggianella M; Marchese S; Mossenta M; Rana J; Arnoldi F; Bestagno M; Burrone OR
PLoS One; 2017; 12(7):e0181734. PubMed ID: 28742857
[TBL] [Abstract][Full Text] [Related]
10. CD4 T Cell Determinants in West Nile Virus Disease and Asymptomatic Infection.
Koblischke M; Spitzer FS; Florian DM; Aberle SW; Malafa S; Fae I; Cassaniti I; Jungbauer C; Knapp B; Laferl H; Fischer G; Baldanti F; Stiasny K; Heinz FX; Aberle JH
Front Immunol; 2020; 11():16. PubMed ID: 32038660
[TBL] [Abstract][Full Text] [Related]
11. Recombination of B- and T-cell epitope-rich loci from Aedes- and Culex-borne flaviviruses shapes Zika virus epidemiology.
Gaunt MW; Gubler DJ; Pettersson JH; Kuno G; Wilder-Smith A; de Lamballerie X; Gould EA; Falconar AK
Antiviral Res; 2020 Feb; 174():104676. PubMed ID: 31837392
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for Zika envelope domain III recognition by a germline version of a recurrent neutralizing antibody.
Esswein SR; Gristick HB; Jurado A; Peace A; Keeffe JR; Lee YE; Voll AV; Saeed M; Nussenzweig MC; Rice CM; Robbiani DF; MacDonald MR; Bjorkman PJ
Proc Natl Acad Sci U S A; 2020 May; 117(18):9865-9875. PubMed ID: 32321830
[TBL] [Abstract][Full Text] [Related]
13. CD4
Wen J; Wang YT; Valentine KM; Dos Santos Alves RP; Xu Z; Regla-Nava JA; Ngono AE; Young MP; Ferreira LCS; Shresta S
Cell Rep; 2020 Apr; 31(4):107566. PubMed ID: 32348763
[TBL] [Abstract][Full Text] [Related]
14. Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection.
Stettler K; Beltramello M; Espinosa DA; Graham V; Cassotta A; Bianchi S; Vanzetta F; Minola A; Jaconi S; Mele F; Foglierini M; Pedotti M; Simonelli L; Dowall S; Atkinson B; Percivalle E; Simmons CP; Varani L; Blum J; Baldanti F; Cameroni E; Hewson R; Harris E; Lanzavecchia A; Sallusto F; Corti D
Science; 2016 Aug; 353(6301):823-6. PubMed ID: 27417494
[TBL] [Abstract][Full Text] [Related]
15. From ZikV genome to vaccine: in silico approach for the epitope-based peptide vaccine against Zika virus envelope glycoprotein.
Alam A; Ali S; Ahamad S; Malik MZ; Ishrat R
Immunology; 2016 Dec; 149(4):386-399. PubMed ID: 27485738
[TBL] [Abstract][Full Text] [Related]
16. A Multiplex Microsphere Immunoassay for Zika Virus Diagnosis.
Wong SJ; Furuya A; Zou J; Xie X; Dupuis AP; Kramer LD; Shi PY
EBioMedicine; 2017 Feb; 16():136-140. PubMed ID: 28094237
[TBL] [Abstract][Full Text] [Related]
17. Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus.
Swanstrom JA; Plante JA; Plante KS; Young EF; McGowan E; Gallichotte EN; Widman DG; Heise MT; de Silva AM; Baric RS
mBio; 2016 Jul; 7(4):. PubMed ID: 27435464
[TBL] [Abstract][Full Text] [Related]
18. Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus.
Dejnirattisai W; Supasa P; Wongwiwat W; Rouvinski A; Barba-Spaeth G; Duangchinda T; Sakuntabhai A; Cao-Lormeau VM; Malasit P; Rey FA; Mongkolsapaya J; Screaton GR
Nat Immunol; 2016 Sep; 17(9):1102-8. PubMed ID: 27339099
[TBL] [Abstract][Full Text] [Related]
19. Development of Envelope Protein Antigens To Serologically Differentiate Zika Virus Infection from Dengue Virus Infection.
Premkumar L; Collins M; Graham S; Liou GA; Lopez CA; Jadi R; Balmaseda A; Brackbill JA; Dietze R; Camacho E; De Silva AD; Giuberti C; Dos Reis HL; Singh T; Heimsath H; Weiskopf D; Sette A; Osorio JE; Permar SR; Miley MJ; Lazear HM; Harris E; de Silva AM
J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29263206
[TBL] [Abstract][Full Text] [Related]
20. Structural Influence on the Dominance of Virus-Specific CD4 T Cell Epitopes in Zika Virus Infection.
Koblischke M; Stiasny K; Aberle SW; Malafa S; Tsouchnikas G; Schwaiger J; Kundi M; Heinz FX; Aberle JH
Front Immunol; 2018; 9():1196. PubMed ID: 29899743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
